During the past decade, Pima Heart and Vascular conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pima Heart and Vascular" #1 sponsor was "Boston Scientific Corporation" with 5 trials, followed by "Impulse Dynamics" with 5 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Amryt Pharma" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pima Heart and Vascular" #1 collaborator was "AXIOM Real Time Metrics" with 1 trials as a collaborator, "Milton S. Hershey Medical Center" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Syntactx" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Pima Heart and Vascular" are "Heart Failure" (6 trials), "Bradycardia" (2 trials), "CHF" (2 trials), "Chronic Heart Disease" (2 trials) and "Congestive Heart Failure" (2 trials). Many other conditions were trialed in "Pima Heart and Vascular" in a lesser frequency.

Most popular intervention types in "Pima Heart and Vascular" are "Device" (18 trials), "Drug" (5 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AMPLATZER™ PFO Occluder" (1 trials), "Anticoagulation Agents" (1 trials), "Boston Scientific Cardiac Cryoablation System" (1 trials) and "COGNIS CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pima Heart and Vascular" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Pima Heart and Vascular". undefined are not yet recruiting, 13 are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 10 completed trials in Pima Heart and Vascular, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pima Heart and Vascular, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".

Pima Heart and Vascular has several departments that took part in Clinical trials: "Pima Vascular" - 3 trials